Description

Sibutramine 15 mg by Swiss Healthcare is a pharmaceutical-grade oral compound historically used as an appetite suppressant in the management of obesity. Although withdrawn from human medical use in many countries due to cardiovascular concerns, it remains a subject of interest in controlled research environments studying weight regulation, central appetite signaling, and energy balance.

Sibutramine functions as a serotonin-norepinephrine reuptake inhibitor (SNRI), modulating neurotransmitters involved in satiety and appetite control. Its primary mechanism in research has shown a reduction in food intake and potential elevation in basal metabolic rate.

Swiss Healthcare manufactures Sibutramine 15 mg under strict pharmaceutical-grade conditions. Each bottle contains 60 capsules, allowing for controlled and consistent oral administration in lab settings.

Product Details

• Active Ingredient: Sibutramine Hydrochloride Monohydrate

• Concentration per Capsule: 15 mg

• Form: Oral capsules

• Package Size: 60 capsules per bottle

Pharmacokinetics

Sibutramine is rapidly absorbed and metabolized in the liver into two active metabolites with half-lives of approximately 14–16 hours. These metabolites are primarily responsible for its anorectic (appetite-suppressing) effects. It has been studied for enhancing satiety and thermogenesis in experimental models.

Usage Recommendations

• Typical Research Dosage (historical reference): 10–20 mg per day

• Current Use: Intended solely for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with cardiovascular or psychiatric conditions. Use in accordance with applicable laws and safety protocols.